⌘K
Loading ticker…
As of 2026-08-24, CRISPR Therapeutics AG (CRSP) has a 3-month relative strength percentile of 72 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.2%, relative volume 0.71×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
CRSP is held by 14 ETFs as of May 2026. Top owner: VTWO at 0.15% weight, $26M notional. Top 3 carry $36M.
Held by 27 ETFs · $544M across latest filings · largest weight 8.91% (ARKG).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| $1M |
| — |
| AVUSAvantis U.S. Equity ETF | 0.01% | $877K | — |
| VTHRVanguard Russell 3000 ETF | 0.01% | $437K | — |
| WSML | 0.05% | $308K | new |
| IBBQ | 0.43% | $289K | — |
Showing 10 of 14 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CRSP Jan avg: 6.75% median: 3.11% win: 75% σ: 13.21% n: 4 2022-04-12 → 2026-07-31 | CRSP Feb avg: 14.11% median: 12.99% win: 75% σ: 16.36% n: 4 2022-04-12 → 2026-07-31 | CRSP Mar avg: -17.70% median: -19.98% win: 0% σ: 6.42% n: 4 2022-04-12 → 2026-07-31 | CRSP Apr avg: -1.93% median: 8.20% win: 60% σ: 17.33% n: 5 2022-04-12 → 2026-07-31 | CRSP May avg: 10.09% median: 7.34% win: 80% σ: 14.37% n: 5 2022-04-12 → 2026-07-31 | CRSP Jun avg: 4.79% median: 0.50% win: 60% σ: 17.51% n: 5 2022-04-12 → 2026-07-31 | CRSP Jul avg: 7.05% median: 6.07% win: 80% σ: 13.51% n: 5 2022-04-12 → 2026-07-31 | CRSP Aug avg: -12.64% median: -12.99% win: 0% σ: 3.63% n: 4 2022-04-12 → 2026-07-31 (current) | CRSP Sep avg: 3.66% median: -0.58% win: 50% σ: 14.85% n: 4 2022-04-12 → 2026-07-31 | CRSP Oct avg: -9.16% median: -7.75% win: 0% σ: 9.42% n: 4 2022-04-12 → 2026-07-31 | CRSP Nov avg: 17.49% median: 7.49% win: 75% σ: 37.75% n: 4 2022-04-12 → 2026-07-31 | CRSP Dec avg: -14.25% median: -14.64% win: 0% σ: 11.95% n: 4 2022-04-12 → 2026-07-31 |